Font Size: a A A

The Possible Mechanism Of Toll-like Receptor 9 In Preeclampsia

Posted on:2019-10-28Degree:DoctorType:Dissertation
Country:ChinaCandidate:B W HeFull Text:PDF
GTID:1484305894958609Subject:Obstetrics and gynecology
Abstract/Summary:PDF Full Text Request
Objective:Preeclampsia(PE)is a common pregnancy-specific disorder characterized by elevated blood pressure and proteinuria.Activation of the maternal immune system and impaired placental angiogenesis are thought to contribute to the pathogenesis of PE.Toll-like receptor 9(TLR9)plays a role in innate immunity,defending the organism against infection.VEGFA(vascular endothelial growth factor A)is the most important proangiogenic factor;s FLT1(soluble vascular endothelial growth factor receptor 1)is an important antiangiogenic protein factor.The purpose of this study is to determine whether TLR9 inhibits angiogenesis by suppressing VEGFA and promoting s FLT1 expression at the maternal-fetal interface under conditions of PE.Methods:1.Patients and tissue collection:Human placental tissues were obtained from women with a normal pregnancy(N=28)or PE(N=22)who were delivered by elective cesarean section.Then we detected the placental levels of TLR9,VEGFA,s FLT1 and pro-inflammatory factors(IL-6,TNF-α,IP-10)in preeclamptic and normal women.2.In vivo experiment:We used TLR9 agonists ODN1826 to establish a PE-like mouse model and examined the blood pressure,proteinuria,fetal development,H&E staining of kidney and placenta in the mouse model.Mice received intraperitoneal injections of ODN1826 on E7.5,E9.5,and E11.5.And then we evaluated the regulation of VEGFA,s FLT1 and several pro-inflammatory factors(IL-6,TNF-α,IP-10)in the placentas of PE-like mouse model.3.In vitro experiment : We explored the regulation of VEGFA and s FLT1 in Cp G-ODN-stimulated cells and si-TLR9-transfected cells.And then we evaluated the effect of si-TLR9 on human trophoblast migration/invasion through transwell assay and wound healing assay.Results:1.Compared to normal women,preeclamptic women had markedly higher levels of TLR9,IL-6,TNF-α,and IP-10 in the placenta.2.Placental s FLT1 levels were upregulated and VEGFA levels were downregulated in women with PE.3.ODN1826 could used to established a PE-like mouse model;it induces hypertension,proteinuria,fetal growth restriction,fetal malformation,placental and kidney disorder in mouse.4.Compared to normal group,PE-like mouse model had higher levels of TLR9,NF-κB p65,IL-6,TNF-α,and IP-10 in the placenta.5.Placental s FLT1 levels were upregulated and VEGFA levels were downregulated in PE-like mouse model.6.ODN2006 treatment of HTR8/SVneo cells significantly increased TLR9 and NF-κB p65 expression in cells.7.VEGFA levels were decreased and s FLT1 levels were increased in ODN2006-treated HTR8/SVneo cells.8.VEGFA levels were increased and s FLT1 levels were decreased in the si-TLR9 group compared to the negative control group;silencing TLR9 promotes the migration and invasion of HTR-8/SVneo cells.Conclusions:1.The alterd expression of TLR9,s FLT1,VEGFA may play a role in the development of preeclampsia in human beings.2.ODN1826 could induce PE-like symptoms in pregnant mice.And ODN1826 could activate TLR9 signalling and induce upregulated s FLT1 levels,downregulated VEGFA levels in the placentas of PE-like mouse model.3.ODN2006 could activate TLR9 signalling and induce increased s FLT1 levels,decreased VEGFA levels in the HTR-8/SVneo cells.And TLR9 si RNA could upregulate VEGFA levels and downregulate s FLT1 levels in the HTR-8/SVneo cells.Silencing TLR9 promotes the migration and invasion of HTR-8/SVneo cells.4.TLR9 is profoundly capable of suppressing angiogenesis by differentially regulating the expression of VEGFA and s FLT1 at the feto-maternal interface,potentially contributing to the development of PE.
Keywords/Search Tags:Preeclampsia, TLR9 (Toll-like receptor 9), VEGFA (Vascular Endothelial Growth Factor A), sFLT1 (Soluble Vascular Endothelial Growth Factor Receptor 1), Angiogenesis
PDF Full Text Request
Related items
Expression Of Hypoxia-inducible Factor-1 Alpha And Vascular Endothelial Growth Factor And Its Receptor-1 In Placenta In Preeclampsia
Studies Of The Correlation Between Vascular Endothelial Growth Factor Soluble Receptor (sflt-1) And Endometriosis Angiogenesis Mechanism
Expression Of Vascular Endothelial Growth Factor And Soluble Fms-like Tyrosine Kinase Receptor 1 Under Different Oxygen Condition In The Primary Cultured Cytotrophoblasts Cells
Circulation Serum SICAM-1 And VEGF,PLGF,Flt-1,sFlt-1 MRNA Expression Of Placenta Tissue In Pregnancy-induced Hypertension
The Expression Of Hypoxia-inducible Factor-1alpha,vascular Endothelial Growth Factor And Its Receptor Kdr,microvessel Density In Endometrial Carcinoma And The Clinical Investigation
The Expression Of Hypoxia-inducible Factor-1alpha,Vascular Endothelial Growth Factor And Its Receptor KDR,Microvessel Density In Endometrial Carcinoma And The Clinical Investigation
Research On Relationship Between Expression Of Vascular Endothelial Growth Factor Receptor-3 And Endothelial Vascular Growth Factor-C And Lymphangiogenesis In Human Laryngeal Carcinoma
Significance And Expression Of Urinary Soluble Vascular Endothelial Growth Factor Receptor-1 In Patients With Endometriosis
The Application Study Of Vascular Endothelial Growth Factor And Its Receptor In Tumor Vascular Targeting Therapy Of Colorectal Carcinoma
10 Suppression Of VEGF Induced Angiogenesis And Tumor Growth By Recombinant T4 Phages Displaying VEGFR2